Oct4, Nanog, Sox2, Tra-1-60 expression
Oct4, Nanog, Sox2, Tra-1-60 expression
Oct4, Nanog, Sox2, Tra-1-60 expression

200 fully characterised iPSCs lines: Oct4, Nanog, Sox2, Tra-1-60 expression. Normal karyotype.

dementia research
  • Detailed patient and antecedent clinical history for each patient cell line.
  • APOE genotyped
dementia research

Our Alzheimer’s disease iPSC portfolio adds power to your studies by ensuring sufficient patient cell lines are analysed to avoid type 1 and type 2 statistical errors.

Our vision is to prevent Alzheimer’s disease from ever progressing to a stage where it exerts physical effects on the individual by identifying interventional approaches that target the latent disease using the right drug at the right time in the right patient.